|
|
|
|
|
|
|
|
abstract
Background
While an elevated risk of second malignant neoplasms (SMNs) has been observed in men treated for germ cell tumors (GCTs),
risk of SMNs have not been quantified in adult women nor in girls treated for GCTs.
Patients and Methods
One-year survivors of primary GCTs
diagnosed between January 1980 and December 2012 were identified from
Surveillance, Epidemiology,
and End Results registries (SEER 9). Risk of SMNs
were calculated using SEER*Stat.
Results
Among 1,507 patients, a total of 47 SMNs
were identified. The overall risk of SMNs was not elevated in females
overall nor
in females treated for GCT during adulthood,
although SMN sites (pancreas, soft tissue, bladder, kidney, thyroid) and
trends
were comparable with those in men. There were too
few childhood GCT cases with SMNs for further analysis.
Conclusions
Unlike men, women treated for GCTs did
not have a statistically significant elevated risk of SMNs (SIR=1.11,
95%CI=0.81-1.47).
The fact that SMNs in women occur in sites similar
to those observed in men indicate that long-term follow-up of a larger
cohort of females treated for GCT is warranted.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.